Evidence map›Paper›PMID 38014342›Full record

ArticlebioRxiv : the preprint server for biology2023

Testing of putative antiseizure drugs in a preclinical Dravet syndrome zebrafish model.

P Whyte-Fagundes, A Vance, A Carroll, F Figueroa, C Manukyan, S C Baraban

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

P Whyte-FagundesEpilepsy Research Laboratory and Weill Institute for Neuroscience, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-4878-9955
A VanceEpilepsy Research Laboratory and Weill Institute for Neuroscience, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
A CarrollBehavioral Neurosciences, Northeastern University, Boston, MA, USA.
F FigueroaEpilepsy Research Laboratory and Weill Institute for Neuroscience, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
C ManukyanHelen Wills Neuroscience Institute, University of California, Berkeley, CA, USA.
S C BarabanEpilepsy Research Laboratory and Weill Institute for Neuroscience, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-1975-9781
University of California, San Francisco · USNortheastern University · USUniversity of California, Berkeley · US

Funding

ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERYR01NS096976 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARABAN, SCOTT C · 2016 to 2024
$3.9M
NINDS NIH HHS R01 NS096976
6 · The paper itself

Abstract

Dravet syndrome (DS) is a severe genetic epilepsy primarily caused by

Indexed as

Anti-seizure medicationsDravetDrug screeningEpilepsyZebrafish larvae

Identifiers

PMID38014342
PMCPMC10680609
OpenAlexW4388692231

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.